| Independent Reports (Showing 1 to 10 of 27) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 9-Feb-10 | New Constructs, LLC | N/A | VOLC: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 | $10 | View Abstract |
| 7-Feb-10 | Wright Reports | N/A | Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) | 100 | $169 | View Abstract |
| 7-Feb-10 | Wright Reports | N/A | Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) | 98 | $169 | View Abstract |
| 5-Feb-10 | Jefferson Research | N/A | Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of VOLCANO CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 11 | $20 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Value Graph: VOLCANO -- VOLC | 1 | $4 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ANGO , CPHD , HTRN , ISR , NMTI , NUVA , VOLC -- MEDICAL SUPPLIES & EQUIPMENT | 3 | $4 | View Abstract |
| 3-Feb-10 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Volcano Corporation | 41 | $65 | View Abstract |
| 2-Feb-10 | EconomicInvestor | N/A | "The Economy Matters" Report for VOLC: the economy's impact on VOLC's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 | $15 | View Abstract |
| 25-Jan-10 | Wall Street Transcript ,The | The Wall St Transcript | ANALYST INTERVIEW: Blurred Lines Between Life Sciences & Diagnostics - Stephen D. Simpson - Northland Securities, Inc. | 5 | $50 | View Abstract |
| 25-Jan-10 | Wall Street Transcript ,The | The Wall St Transcript | Wall Street Transcript Special Report: Medical Research, Diagnostic Substances, Life Science Tools Report | 35 | $150 | View Abstract |